Clinical Trial Update: Serum Lipoprotein-a as a Marker of Severity of Coronary Artery Disease in Aortic Valve Sclerosis Patients

View source ↗

Summary

This completed clinical trial evaluates whether serum lipoprotein(a) serves as a biomarker for the severity of coronary artery disease in patients with aortic v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Sclerosis
• Coronary Artery Disease

Snippet

Sponsor: Sohag University | Conditions: Serum, Lipoprotein(A) | Status: COMPLETED